Carbamazepine

Product NDC
67877-797
11-digit product format
678770797
Labeler code
67877
Product ID
67877-797_f712b540-b6b2-4fc7-a7b4-38b3a8e51964
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Carbamazepine
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Ascend Laboratories, LLC
Application
ANDA217277
Marketing category
ANDA
Marketing start
2025-11-01
Substance
CARBAMAZEPINE
Active strength
100 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
33CM23913MCARBAMAZEPINE298-46-4CARBAMAZEPINE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
67877-797-0167877079701100 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-797-01) 2025-11-01NoNoHistorical
67877-797-0567877079705500 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-797-05) 2025-11-01NoNoHistorical
67877-797-306787707973030 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-797-30) 2025-11-01NoNoHistorical
67877-797-33678770797331 BLISTER PACK in 1 CARTON (67877-797-33) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK1 blister pack2025-11-01NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
CarbamazepineAscend Laboratories, LLC | Alkem Laboratories Limited2025-11-03Human Prescription Drug Label5